Brief: Virpax Pharmaceuticals Says Fot Written Notification From Nasdaq Granting Co's Request For 180-Day Extension To Regain Compliance
11/10/2023 21:54
Oct 11 (Reuters) - Virpax Pharmaceuticals Inc VRPX.O :
* VIRPAX PHARMACEUTICALS - ON OCT 10, FOT WRITTEN
NOTIFICATION
FROM NASDAQ GRANTING CO'S REQUEST FOR 180-DAY EXTENSION TO
REGAIN COMPLIANCE
Further company coverage: VRPX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Virpax Pharmaceuticals
See all newsVirpax Pharma plunges as Nasdaq delisting looms
Brief: Virpax Pharmaceuticals Files For Offering On Best Efforts Basis Up To 2.4 Million Shares Of Common Stock
Brief: Virpax receives positive Probudur™ results for dose range study
Brief: Virpax Looking To Use Met To Develop Intranasal Covid Vaccine
Brief: Virpax Confirms Positive Results With Us Army With Probudur™ For Combat Care Study